About 200 doctors and nurses attended the "Asian Culture for Asian Games" Intercultural Communication Lectures on April 21 Friday. The healthcare professionals are from more than 30 hospitals across Zhejiang province and are going to provide medical services for the upcoming Asian Games and the Asian Para Games.
To improve the efficacy of the treatment for NSCLC, the outcome of two vs three cycles of neoadjuvant sintilimab combined with chemotherapy in resectable stage IB-IIIA NSCLC patients was recently evaluated by Prof. QIU Fuming, a medical oncologist at SAHZU, and Prof. FAN Junqiang, a cardiac surgeon at SAHZU (NCT04459611).
This spring saw the return after three years of international students and physicians to the campuses of SAHZU.
Prof. YAO Ke, chair of SAHZU Eye Center, was ranked Top 8 in the 1st Asia-Pacific Eye 100. The honor is awarded to the top 100 most influential figures in ophthalmology in the Asia-Pacific region.
A multicenter clinical study led by Prof. LU Qin, academic chair of SAHZU Emergency Medicine, and Prof. ZHANG Mao, chair of SAHZU Emergency Medicine and vice president of SAHZU, has looked into the occurrence and evolution of venous catheter-related thrombosis in critically ill patients using point-of-care ultrasound.
A novel probiotic therapy that can alleviate intestinal inflammation and microbiota dysbiosis in IBD has been reported by a cross-disciplinary research team from Zhejiang University, which provides a potential new treatment approach for enterohepatic circulation in patients with severe and chronic liver diseases.
On March 8, four female members of the 28th Chinese medical team were featured on the front page of “Aujourd’hui, a leading newspaper in the African country of Mali where the medical team is providing their humanitarian services.
Chair of SAHZU Nuclear Medicine Prof. ZHANG Hong and his team published an article on Nano Today entitled Precise Examination of Peripheral Vascular Disease for Diabetics with a Novel Multiplexed NIR-II Fluorescence Imaging Technology.
Once a happy and energetic boy, Ding now has to have a liver transplant because of his deadly illness. The story starts with self-prescribed folk medicine.
SAHZU Cardiac Rehabilitation Center is recognized as the "Certified Cardiac Rehabilitation Center" and the "National Demonstration of Cardiac Rehabilitation", becoming the fifth nationally accredited cardiovascular programs at SAHZU Heart Center, besides Heart Failure Center, Atrial Fibrillization Center, Hypertension Center and Chest Pain Center. The announcement was made at the Chinese Cardiovascular Health Conference on December 10, 2022.
SAHZU President and Academician of Chinese Academy of Sciences, Prof. WANG Jian'an was invited to Kocaeli University School of Medicine to proctor transcatheter aortic valve replacement (TAVR) procedures using China's self-developed devices, on July 22.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell1 in March 2024.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).